Loading…
Armata Pharmaceuticals Inc Is A Late Clinical-Stage Biotechnology Company Focused On The Development Of High-Purity And Potent, Pathogen-Specific Bacteriophage Therapeutics For The Treatment Of Antibiotic-Resistant And Difficult-To-Treat Bacterial Infections Using Proprietary Bacteriophage-Based Technology. It Has Completed Three Phase 2 Clinical Trials To Date. The Company Operates And Manages Its Business As One Reportable Operating Segment, Which Is The Business Of Developing Pathogen-Specific Bacteriophage Therapeutics For The Treatment Of Antibiotic-Resistant And Difficult-To-Treat Acute And Chronic Bacterial Infections Using Its Proprietary Bacteriophage-Based Technology.